01 May 2014 --- Rousselot has released the results of its new integrated study assessing the beneficial effects of its Peptan collagen peptides on bone mass formation and preservation. Conducted in collaboration with the French National Institute for Agricultural Research, INRA, the combined in vivo and in vitro study reinforces existing scientific evidence regarding the ability of collagen peptides to support the development of bone formation cells and assist osteopenia prevention.
